My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Location

Published Date

Displaying 21-27 of 27 results for

GO
Search Filters: Massachusetts cancel New York cancel New Jersey cancel

2023 Legislative Session Update: Part Two

Blog,
Health Policy Update,
Policy,
State Health Policy,
Public Health Law,
Population Health and Prevention,
Women, Infant, and Family Health,
Contraception Access,
Women, Infant, Family Health Data Integration,
Data Modernization and Informatics,
Health Equity,
Infectious Disease,
Immunization,
Public Health Workforce,
Public Health Infrastructure and Systems Improvement,
California,
Connecticut,
Indiana,
Iowa,
Maine,
Maryland,
Massachusetts,
Missouri,
Montana,
New Jersey,
New York,
Oklahoma,
Rhode Island,
Texas,
Vermont,
Washington,
Maggie Davis,
Andy Baker-White,
Lillian Colasurdo,
Lana McKinney

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: data privacy and modernization, reproductive health, health equity, strengthening public health agencies, and immunization.

Avoiding ACEs by Helping Families During COVID-19

Blog,
Health Policy Update,
Policy,
State Health Policy,
Infectious Disease,
COVID-19,
COVID and Health Equity/Health Disparities,
COVID and Community Mitigation,
Arizona,
California,
Kentucky,
Maine,
Massachusetts,
New Jersey,
New York,
Ohio,
South Carolina,
Vermont,
Washington,
Washington, D.C.,
Alaska

This Health Policy Update is an overview of state legislative activity to increase financial stability for families during the COVID-19 pandemic which may help to prevent adverse childhood experiences.

Prevention and Response Policies to Reduce Overdoses Involving Synthetic Opioids

Blog,
Health Policy Update,
Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Opioids,
Arizona,
Connecticut,
Florida,
Iowa,
Louisiana,
Massachusetts,
Michigan,
New Hampshire,
New Jersey,
New York,
North Carolina,
Virginia

Learn how state legislation is expanding access to drug checking equipment and screening in this Health Policy Update.

As Families Seek More Work / Life Balance, States Consider Leave Policies

Blog,
Health Policy Update,
Policy,
State Health Policy,
Population Health and Prevention,
Women, Infant, and Family Health,
California,
Colorado,
Connecticut,
Delaware,
Hawaii,
Maryland,
Massachusetts,
Minnesota,
New Jersey,
New York,
Oregon,
Rhode Island,
Virginia,
Washington,
Beth Giambrone,
Topics,
Work/Life Balance,
Change Level,
Organization/Agency,
Senior Leadership,
Resource Type,
Briefs/Articles

An ASTHO blog article on leave policies to support better work/life balance.

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...

Handle with Care: State Newborn Screening Policies

Blog,
Health Policy Update,
Population Health and Prevention,
Women, Infant, and Family Health,
Infant and Child Health,
Policy,
State Health Policy,
Public Health Law,
Arkansas,
California,
Connecticut,
Louisiana,
Maryland,
Massachusetts,
Montana,
New Hampshire,
New Jersey,
New York,
Pennsylvania,
Texas,
Utah,
Wisconsin,
Christina Severin,
Lauren Jones

In the U.S., jurisdictions vary in their newborn screening practices and requirements related to the scope of testing, approach to parental consent, options for blood sample destruction, sample retention periods, and permissible uses of ...